Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Bioanalysis ; 12(14): 1033-1038, 2020 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-32706625

RESUMEN

In this paper, the European Bioanalysis Forum reports back from the discussions with software developers, involved in regulated bioanalysis software solutions, on agreeing to data transfer specification in the bioanalytical labs' LC-MS workflows as part of today's Data Integrity (DI) challenges. The proposed specifications aim at identifying what consists of a minimum dataset, that is, which are the pre-identified fields to be included in DI proof bidirectional data transfer between LC-MS and information management systems. The proposal is an attempt from the European Bioanalysis Forum to facilitate new software solutions becoming available to increase compliance related to DI in today's LC-MS workflows. The proposal may also serve as a template and inspiration for new data transfer solutions in other workflows.


Asunto(s)
Bioensayo/métodos , Cromatografía Liquida/métodos , Espectrometría de Masas en Tándem/métodos , Europa (Continente) , Humanos
2.
Bioanalysis ; 11(13): 1227-1231, 2019 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-31452404

RESUMEN

In this conference report, we summarize the main findings and messages from a workshop on 'Data Integrity'. The workshop was held at the 11th European Bioanalysis Forum Open (EBF) Symposium in Barcelona (21-23 November 2018), in collaboration with the Medicines and Health products Regulatory Agency to provide insight and understanding of regulatory data integrity expectations. The workshop highlighted the importance of engaging with software developers to address the gap between industry's data integrity needs and current system software capabilities. Delegates were also made aware of the importance of implementing additional procedural controls to mitigate the risk associated with using systems that do not fully meet data integrity requirements.


Asunto(s)
Bioensayo , Preparaciones Farmacéuticas/análisis , Bioensayo/normas , Exactitud de los Datos , Regulación Gubernamental , Preparaciones Farmacéuticas/normas , Control de Calidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...